![SonomaEye-full-color-vector[2].png](https://static.wixstatic.com/media/bed00b_da20b9cc704044b0b048ac8ef9190470~mv2_d_3024_2195_s_2.png/v1/fill/w_177,h_122,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/SonomaEye-full-color-vector%5B2%5D.png)
Suprachoroidal triamcinolone injection in nodular posterior scleritis: a case report
Presenter:
Ploysai Rujkorakarn, MD
Authors:
Ploysai Rujkorakarn, Avery Zhou, Fatima Babiker, Peter Y Chang
1-4: Massachusetts Eye Research and Surgery Institution, 1440 Main St #201, Waltham, MA 02451
1-4: The Ocular Immunology and Uveitis Foundation, 1440 Main St #201, Waltham, MA 02451
Affiliation:
Purpose: To report the first case of suprachoroidal triamcinolone injection used in treating nodular posterior scleritis.
Methods: Single-case, retrospective review of ophthalmological and systemic manifestations.
Results: A 67-year-old woman with nodular posterior scleritis diagnosed by spectral-domain optical coherence tomography scan had persistent pain, decreased vision, and redness in the left eye for the past 8 months. She had been prescribed topical prednisolone and prednisone with minimal improvement. She also had a history of rheumatoid arthritis treated with etanercept. She was given an injection of suprachoroidal triamcinolone in the left eye. Pain, visual acuity, and inflammation improved at the 11-day follow-up and 5-week follow-up.
Conclusions: Suprachoroidal triamcinolone may be investigated as an adjunctive therapy in refractory cases of nodular posterior scleritis.